Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
new york blog main
6
×
new york top stories
biotech
boston blog main
boston top stories
national top stories
san francisco blog main
san francisco top stories
san diego blog main
san diego top stories
boston
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
biotech ipos
deals
depression
diagnostics
drugs
hepatitis b
medical device
merck
What
way
6
×
week
biotechs
drug
ipo
ipos
life
make
medical
medicine
science
acquisitions
alnylam
approves
biggest
bio
biotech
boost
build
buy
cancer
cells
centers
central
ceo
chose
close
cns
companies
company
company’s
cut
daniel
debut
depression
device
disorder
drugs
dyne’s
ema
Language
unset
Current search:
" new york blog main "
×
way
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?